Carbamazepine, also known as Tegretol, is an anticonvulsant drug and analgesic drug used to control seizures and to treat pain resulting from trigeminal neuralgia. It was initially approved by the FDA in 1965. Aside from the above uses, this drug is also given to control the symptoms of bipolar 1. Interestingly, carbamazepine was the first anticonvulsant use...
Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia. In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures. Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive e...
Madison, Wisconsin, Madison, Wisconsin, United States
Clinical Pharmacology Unit, Merksem, Belgium
Nuvisan GmbH, Neu-Ulm, Bavaria, Germany
Nuvisan GmbH, Neu-Ulm, Germany
LabCorp CRU, Inc., Daytona Beach, Florida, United States
CRS Clinical-Research-Services Mannheim GmbH, Mannheim, Baden-Württemberg, Germany
PGIDS, Rohtak, Haryana, India
Post Graduate Institute of Dental Sciences, Rohtak, Haryana, India
Pfizer New Haven Clinical Research Unit, New Haven, Connecticut, United States
Toronto Western Hospital, Toronto, Ontario, Canada
LabCorp CRU, Inc., Daytona Beach, Florida, United States
Covance Dallas, Dallas, Texas, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.